Company Profile
JanOne Stock Price, News & Catalysts
- Ticker:
- JAN
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
31.20 USD (+1.60%)
Close
Last updated: August 24, 2026
4.76B USD
Market cap
Why the stock is moving
As of Aug 24, 2026, JAN closed up 1.60% at $31.20. No new same-company headline was identified in the current news window.
Company overview
Business overview
JanOne was a biotechnology or life-sciences company that went through multiple strategic transformations and rebrandings over time. Its story is best understood as a historical small-cap name rather than a stable therapeutic franchise.
Geographic Base and Sector Classification
JanOne was headquartered in the United States and listed on NASDAQ. It sat in small-cap biotech and life sciences.
Business Model Characteristics
The company depended on corporate strategy, capital allocation, and the ability to find a sustainable business identity. Investors historically watched restructurings and repositioning efforts.
Position Within the Biotechnology Landscape
JanOne belongs to the historical repositioning bucket within the biotech universe. It is a legacy ticker where strategy mattered as much as science.
Future catalysts
- JanOne is now largely a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live development milestone. The market is focused on what remains.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of JanOne (JAN)?
JanOne (JAN) most recently closed at 31.20 USD, a +1.60% move versus the previous session.
What is the market cap of JanOne (JAN)?
JanOne currently has a market capitalization of 4.76B USD on BioPharmSignal.
What does JanOne do?
JanOne was a biotechnology or life-sciences company that went through multiple strategic transformations and rebrandings over time. Its story is best understood as a historical small-cap name rather than a stable therapeutic franchise.
On which exchange is JAN stock listed?
JanOne (JAN) is associated with NASDAQ, United States, Biopharma.
What is JanOne?
JanOne is now largely a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live development milestone.
Which conditions is JanOne targeting with JanOne?
JanOne is now largely a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live development milestone.
How does JanOne describe recent progress with JanOne?
JanOne is now largely a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live development milestone.
What future catalysts are investors watching for JanOne?
JanOne is now largely a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a live development milestone. The market is focused on what remains.